Neutralizing IL-6 or blocking IL-6 receptors would inhibit IL-6/IL-6 receptor axis, abrogate the protection of tumor cells from spontaneous- and drug-induced apoptosis, and improve the cellular sensitivity to chemotherapy agents [5, 7, 10]. The gene discussed is IL6; the disease is neoplasm.